About the Advanced Therapies Skills Training Network
About the ATSTN
Backed by £4.7 million in funding from the Department for Business, Energy & Industrial Strategy (BEIS) and Innovate (IUK), the Advanced Therapies Skills Training Network (ATSTN) has been developed as a national initiative to drive growth across the advanced therapies and vaccine manufacturing industry, through offering access to training facilities and an online training platform which can address the UK’s demand for skills.
The industry-need
Employment in the UK cell and gene therapy industry is projected to double by 2024, with the greatest increase projected across bioprocessing roles within manufacturing and supply chain. The Cell and Gene Therapy Catapult 2019 Skills Demand Survey indicated that on average, 60% of new staff employed would already have industry skills and experience, reflecting an urgent demand for upskilling talent from similar industries into the cell and gene therapy space as well as developing new specialists to support this rapidly growing sector.
Through increasing the connectivity of existing industry related training resources, whilst building new pathways, educational programmes and specific training content, the ATSTN is able to support the uptake of new talent from different sectors whilst upskilling existing staff to minimise these present skill gaps.
